ATI Maternal Newborn Nursing
Diaphragm - ANSWER-Spermicide must be applied with each act of sexual intercourse and
should remain in place 6 hrs after. Empty bladder prior to coitus
Transdermal contraceptive patch - ANSWER-Patch applied to dry skin overlying subQ
tissue, excluding breast
Depo-Provera - ANSWER-IM injection given every 11-13 weeks (start should be during first
5 days of clients menstrual cycle)
Essure - ANSWER-Insertion of agent resulting in development of scar tissue in Fallopian
tubes. Not reversible
Female sterilization - ANSWER-Burning or blocking the Fallopian tubes. Not reversible
Vasectomy - ANSWER-Ligation and severance of vas deferens. Need alternate form of birth
control for 20 ejaculations
RhoGAM - ANSWER-Administered at 28 weeks gestation to a mother who is Rh-negative
and gives birth to an Rh-positive infant. Recommended following an amniocentesis
Oxytocin (Pitocin) - ANSWER-Monitor for water intoxication (lightheaded, n/v, headache,
malaise) which can lead to cerebral edema, seizures, coma, and death. Contraindicated based
on late decelerations
3 hour glucose tolerance test - ANSWER-Screens for gestational diabetes and is done at 28
weeks of gestation
Rubella titer - ANSWER-Obtained at initial prenatal visit (about 6 weeks gestation)
Betamethasone (Celestone) - ANSWER-Glucocorticoid administered IM in 2 injections 24 hr
apart, given to stimulate fetal lung maturity if early delivery is anticipated and to prevent
respiratory distress. Can cause pulmonary edema (crackles, chest pain, SOB)
,Leopold Maneuver - ANSWER-Abdominal palpation of fetus, lie, attitude, helps nurse assess
the position of the fetus to determine the optimal placement of the fetal monitoring
transducer. Empty bladder beforehand, supine positioning
Steps of Leopold Maneuver - ANSWER-Palpate client's fundus, determine location of fetal
back, palpate fetal part presenting at the inlet, and palpate the cephalic prominence to identify
the attitude of the head
Ferning test - ANSWER-If positive, indicates rupture of membranes
Expected newborn temp - ANSWER-36.5-37.2
Expected newborn HR - ANSWER-120-160
Expected newborn RR - ANSWER-30-60
Expected newborn BP - ANSWER-60-80 S, 40-50 D
Expected newborn length - ANSWER-45-55 cm
Expected newborn weight - ANSWER-2,500-4,000 g
What is effleurage? - ANSWER-Client strokes abdomen using circular motion during
contractions
Maternal Serum Alpha-Fetoprotein - ANSWER-Screening tool for neural tube defects that is
effective between 15 and 22 weeks. levels above indicate the need for an ultrasound
Position for transvaginal ultrasound - ANSWER-Lithotomy position
Biophysical profile assesses? - ANSWER-Fetal
HR, breathing, body movements, fetal tone, and qualitative amniotic fluid volume
What does biophysical profile indicate? - ANSWER-The risk of asphyxia
Nonstress test - ANSWER-Client presses a button whenever they feel fetal movement which
allows nurse to assess FHR in relationship to the fetal movement
Reactive stress test - ANSWER-FHR has moderate variability, accelerated to 15 beats/min
for at least 15 seconds and occurs two or more times during a 20 minute period
, Nonreactive stress test - ANSWER-FHR does not accelerate adequately with fetal movement.
Does not meet criteria after 40 minutes. Contraction stress test or biophysical profile is
indicated
Contraction stress test - ANSWER-FHR in response to contractions which decreases
placental blood flow
Amniocentesis - ANSWER-Performed after 14 weeks gestation, empty bladder beforehand,
client in supine position
High levels of AFP - ANSWER-Alpha-Fetoprotein is measured between 16 and 18 weeks
and is used to detect neural tube defects (anencephaly), spina bifida, and omphalocele
Low levels AFP - ANSWER-Chromosomal disorders (Down syndrome)
Fetal lung tests - ANSWER-Lecithin/sphingomyelin ratio- 2:1 indicating lung maturity or 3:1
for diabetes mellitus
Percutaneous blood sampling - ANSWER-Obtains fetal blood from umbilical cord which
evaluates isoimmune fetal hemolytic anemia and assesses need for fetal blood transfusion
Chorionic Villus sampling - ANSWER-Alternative to amniocentesis (10-12 weeks gestation)
Quad marker screening - ANSWER-Blood test that ascertains info about likelihood of fetal
birth defects. Includes AFP, hCG, Estriol, Inhibin-A
Placenta previa - ANSWER-Placenta abnormally implants in the lower segment of the uterus
near or over the cervix. Results in abnormal bleeding during the 3rd trimester as cervix
begins to dilate
Placenta previa- marginal or low lying - ANSWER-Placenta is attached to lower uterine
segment but does not reach cervix
Signs of placenta previa - ANSWER-Painless vaginal bleeding
Abruptio placenta - ANSWER-Premature separation of placenta from uterus. Can occur after
20 weeks gestation
Diaphragm - ANSWER-Spermicide must be applied with each act of sexual intercourse and
should remain in place 6 hrs after. Empty bladder prior to coitus
Transdermal contraceptive patch - ANSWER-Patch applied to dry skin overlying subQ
tissue, excluding breast
Depo-Provera - ANSWER-IM injection given every 11-13 weeks (start should be during first
5 days of clients menstrual cycle)
Essure - ANSWER-Insertion of agent resulting in development of scar tissue in Fallopian
tubes. Not reversible
Female sterilization - ANSWER-Burning or blocking the Fallopian tubes. Not reversible
Vasectomy - ANSWER-Ligation and severance of vas deferens. Need alternate form of birth
control for 20 ejaculations
RhoGAM - ANSWER-Administered at 28 weeks gestation to a mother who is Rh-negative
and gives birth to an Rh-positive infant. Recommended following an amniocentesis
Oxytocin (Pitocin) - ANSWER-Monitor for water intoxication (lightheaded, n/v, headache,
malaise) which can lead to cerebral edema, seizures, coma, and death. Contraindicated based
on late decelerations
3 hour glucose tolerance test - ANSWER-Screens for gestational diabetes and is done at 28
weeks of gestation
Rubella titer - ANSWER-Obtained at initial prenatal visit (about 6 weeks gestation)
Betamethasone (Celestone) - ANSWER-Glucocorticoid administered IM in 2 injections 24 hr
apart, given to stimulate fetal lung maturity if early delivery is anticipated and to prevent
respiratory distress. Can cause pulmonary edema (crackles, chest pain, SOB)
,Leopold Maneuver - ANSWER-Abdominal palpation of fetus, lie, attitude, helps nurse assess
the position of the fetus to determine the optimal placement of the fetal monitoring
transducer. Empty bladder beforehand, supine positioning
Steps of Leopold Maneuver - ANSWER-Palpate client's fundus, determine location of fetal
back, palpate fetal part presenting at the inlet, and palpate the cephalic prominence to identify
the attitude of the head
Ferning test - ANSWER-If positive, indicates rupture of membranes
Expected newborn temp - ANSWER-36.5-37.2
Expected newborn HR - ANSWER-120-160
Expected newborn RR - ANSWER-30-60
Expected newborn BP - ANSWER-60-80 S, 40-50 D
Expected newborn length - ANSWER-45-55 cm
Expected newborn weight - ANSWER-2,500-4,000 g
What is effleurage? - ANSWER-Client strokes abdomen using circular motion during
contractions
Maternal Serum Alpha-Fetoprotein - ANSWER-Screening tool for neural tube defects that is
effective between 15 and 22 weeks. levels above indicate the need for an ultrasound
Position for transvaginal ultrasound - ANSWER-Lithotomy position
Biophysical profile assesses? - ANSWER-Fetal
HR, breathing, body movements, fetal tone, and qualitative amniotic fluid volume
What does biophysical profile indicate? - ANSWER-The risk of asphyxia
Nonstress test - ANSWER-Client presses a button whenever they feel fetal movement which
allows nurse to assess FHR in relationship to the fetal movement
Reactive stress test - ANSWER-FHR has moderate variability, accelerated to 15 beats/min
for at least 15 seconds and occurs two or more times during a 20 minute period
, Nonreactive stress test - ANSWER-FHR does not accelerate adequately with fetal movement.
Does not meet criteria after 40 minutes. Contraction stress test or biophysical profile is
indicated
Contraction stress test - ANSWER-FHR in response to contractions which decreases
placental blood flow
Amniocentesis - ANSWER-Performed after 14 weeks gestation, empty bladder beforehand,
client in supine position
High levels of AFP - ANSWER-Alpha-Fetoprotein is measured between 16 and 18 weeks
and is used to detect neural tube defects (anencephaly), spina bifida, and omphalocele
Low levels AFP - ANSWER-Chromosomal disorders (Down syndrome)
Fetal lung tests - ANSWER-Lecithin/sphingomyelin ratio- 2:1 indicating lung maturity or 3:1
for diabetes mellitus
Percutaneous blood sampling - ANSWER-Obtains fetal blood from umbilical cord which
evaluates isoimmune fetal hemolytic anemia and assesses need for fetal blood transfusion
Chorionic Villus sampling - ANSWER-Alternative to amniocentesis (10-12 weeks gestation)
Quad marker screening - ANSWER-Blood test that ascertains info about likelihood of fetal
birth defects. Includes AFP, hCG, Estriol, Inhibin-A
Placenta previa - ANSWER-Placenta abnormally implants in the lower segment of the uterus
near or over the cervix. Results in abnormal bleeding during the 3rd trimester as cervix
begins to dilate
Placenta previa- marginal or low lying - ANSWER-Placenta is attached to lower uterine
segment but does not reach cervix
Signs of placenta previa - ANSWER-Painless vaginal bleeding
Abruptio placenta - ANSWER-Premature separation of placenta from uterus. Can occur after
20 weeks gestation
